1MRKX:BIT
Merck & Co Inc
€128,18
arrow_downward
-0,59%(-0,76) 1D
2 ຕ.ລ., 17 ໂມງ 26 ນາທີ 00 ວິນາທີ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
Merck (MRK) Reports a Negative Operating Margin and Pays Out 266% of Earnings. What Explains Both?
MarketBeat
·
1 ຊົ່ວໂມງກ່ອນ
9,102 Merck & Co., Inc. $MRK Shares Acquired by Fragasso Financial Advisors Inc
TipRanks
·
1 ຊົ່ວໂມງກ່ອນ
Merck appoints Paul Diaz to its board of directors
The Pharma Letter
·
3 ຊົ່ວໂມງກ່ອນ
Nimbus hires Merck & Co dealmaker as chief business officer
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia